{
    "info": {
        "nct_id": "NCT03867097",
        "official_title": "A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis",
        "inclusion_criteria": "* Male or female subjects must be greater than or equal to 18 years of age\n* Subjects must have a diagnosis of Systemic Sclerosis\n* Subjects must have a diagnosis or history of Raynaud's Phenomenon\n* Subjects must have a minimum of 10 symptomatic Raynaud's Phenomenon attacks\n* Female subjects of childbearing potential and male subjects must agree to use contraception for the duration of the study\n* Subjects must be willing and able to comply with the study requirements and give informed consent for participation in the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Female subjects who are pregnant or breastfeeding\n* Subjects with systolic blood pressure <85 mmHg\n* Subjects with an estimated glomerular filtration rate <30 mL/min/1.73 m2\n* Subjects with Child-Pugh Class B or Class C liver disease or an alanine aminotransferase and/or aspartate aminotransferase value >3 Ã— the upper limit of normal at screening.\n* Subjects with gangrene, digital ulcer infection, or requirement of cervical or digital sympathectomy\n* Subjects with intractable diarrhea or vomiting\n* Subjects with a risk of clinically significant bleeding events including those with coagulation or platelet disorders\n* Subjects with a history of major trauma or hemorrhage\n* Subjects with clinically significant chronic intermittent bleeding such as active gastric antral vascular ectasia or active peptic ulcer disease\n* Subjects who have had any cerebrovascular events\n* Subjects with a history of myocardial infarction or unstable angina within 6 months of screening\n* Subjects with acute or chronic congestive heart failure\n* Subjects with a history of life-threatening cardiac arrhythmias\n* Subjects with a history of hemodynamically significant aortic or mitral valve disease\n* Subjects with more than mild restrictive or congestive cardiomyopathy uncontrolled by medication or implanted device.\n* Subjects with known pulmonary hypertension, pulmonary arterial hypertension, or pulmonary veno-occlusive disease\n* Subjects with a history of significant restrictive lung disease defined as forced vital capacity <45% predicted and diffusing capacity of the lungs for carbon monoxide <40% predicted (uncorrected for hemoglobin).\n* Subjects with a history of cervical or digital sympathectomy\n* Subjects with scleroderma renal crisis\n* Subjects with a concomitant life-threatening disease with a life expectancy <12 months\n* Subjects who have a clinically significant disorder, that in the opinion of the Investigator, could contraindicate the administration of study drug, affect compliance, interfere with study evaluations, or confound the interpretation of study results\n* Subjects who have taken or are currently taking any parenteral, inhaled, or oral prostacyclin or prostacyclin receptor agonists\n* Subjects must not initiate dosing of oral, topical, or intravenous (IV) vasodilators or if currently receiving any vasodilator must have been stably medicated\n* Subjects with any history of acetaminophen intolerability\n* Subjects with any malignancy that requires treatment during the study period, that has required treatment within 1 year of screening, or that is currently not in remission.\n* Subjects who have used any investigational medication or device for any indication within 30 days or 5 half-lives (whichever is longer)",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subjects of childbearing potential and male subjects must agree to use contraception for the duration of the study",
            "criterions": [
                {
                    "exact_snippets": "Female subjects of childbearing potential ... must agree to use contraception for the duration of the study",
                    "criterion": "contraception use (female subjects of childbearing potential)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "for the duration of the study"
                        }
                    ]
                },
                {
                    "exact_snippets": "male subjects must agree to use contraception for the duration of the study",
                    "criterion": "contraception use (male subjects)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "for the duration of the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have a minimum of 10 symptomatic Raynaud's Phenomenon attacks",
            "criterions": [
                {
                    "exact_snippets": "minimum of 10 symptomatic Raynaud's Phenomenon attacks",
                    "criterion": "symptomatic Raynaud's Phenomenon attacks",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "attacks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have a diagnosis of Systemic Sclerosis",
            "criterions": [
                {
                    "exact_snippets": "diagnosis of Systemic Sclerosis",
                    "criterion": "Systemic Sclerosis diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have a diagnosis or history of Raynaud's Phenomenon",
            "criterions": [
                {
                    "exact_snippets": "diagnosis or history of Raynaud's Phenomenon",
                    "criterion": "Raynaud's Phenomenon",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_or_history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male or female subjects must be greater than or equal to 18 years of age",
            "criterions": [
                {
                    "exact_snippets": "Male or female subjects",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "greater than or equal to 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must be willing and able to comply with the study requirements and give informed consent for participation in the study",
            "criterions": [
                {
                    "exact_snippets": "willing and able to comply with the study requirements",
                    "criterion": "compliance with study requirements",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "give informed consent for participation in the study",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Subjects with systolic blood pressure <85 mmHg",
            "criterions": [
                {
                    "exact_snippets": "systolic blood pressure <85 mmHg",
                    "criterion": "systolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 85,
                                "unit": "mmHg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a concomitant life-threatening disease with a life expectancy <12 months",
            "criterions": [
                {
                    "exact_snippets": "concomitant life-threatening disease",
                    "criterion": "concomitant life-threatening disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "life expectancy <12 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a risk of clinically significant bleeding events including those with coagulation or platelet disorders",
            "criterions": [
                {
                    "exact_snippets": "risk of clinically significant bleeding events",
                    "criterion": "risk of clinically significant bleeding events",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "coagulation or platelet disorders",
                    "criterion": "coagulation disorders",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "coagulation or platelet disorders",
                    "criterion": "platelet disorders",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with an estimated glomerular filtration rate <30 mL/min/1.73 m2",
            "criterions": [
                {
                    "exact_snippets": "estimated glomerular filtration rate <30 mL/min/1.73 m2",
                    "criterion": "estimated glomerular filtration rate",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "mL/min/1.73 m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have a clinically significant disorder, that in the opinion of the Investigator, could contraindicate the administration of study drug, affect compliance, interfere with study evaluations, or confound the interpretation of study results",
            "criterions": [
                {
                    "exact_snippets": "clinically significant disorder, that in the opinion of the Investigator, could contraindicate the administration of study drug, affect compliance, interfere with study evaluations, or confound the interpretation of study results",
                    "criterion": "clinically significant disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "investigator judgment of impact",
                            "expected_value": [
                                "contraindicate the administration of study drug",
                                "affect compliance",
                                "interfere with study evaluations",
                                "confound the interpretation of study results"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with acute or chronic congestive heart failure",
            "criterions": [
                {
                    "exact_snippets": "acute or chronic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "acute",
                                "chronic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with clinically significant chronic intermittent bleeding such as active gastric antral vascular ectasia or active peptic ulcer disease",
            "criterions": [
                {
                    "exact_snippets": "clinically significant chronic intermittent bleeding",
                    "criterion": "chronic intermittent bleeding",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active gastric antral vascular ectasia",
                    "criterion": "gastric antral vascular ectasia",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active peptic ulcer disease",
                    "criterion": "peptic ulcer disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subjects who are pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Female subjects",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with any malignancy that requires treatment during the study period, that has required treatment within 1 year of screening, or that is currently not in remission.",
            "criterions": [
                {
                    "exact_snippets": "any malignancy that requires treatment during the study period",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "requires treatment during study period",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any malignancy ... that has required treatment within 1 year of screening",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "required treatment within 1 year of screening",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any malignancy ... that is currently not in remission",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "remission status",
                            "expected_value": "not in remission"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with known pulmonary hypertension, pulmonary arterial hypertension, or pulmonary veno-occlusive disease",
            "criterions": [
                {
                    "exact_snippets": "known pulmonary hypertension",
                    "criterion": "pulmonary hypertension",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pulmonary arterial hypertension",
                    "criterion": "pulmonary arterial hypertension",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pulmonary veno-occlusive disease",
                    "criterion": "pulmonary veno-occlusive disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with gangrene, digital ulcer infection, or requirement of cervical or digital sympathectomy",
            "criterions": [
                {
                    "exact_snippets": "Subjects with gangrene",
                    "criterion": "gangrene",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "digital ulcer infection",
                    "criterion": "digital ulcer infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requirement of cervical or digital sympathectomy",
                    "criterion": "requirement for cervical or digital sympathectomy",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with scleroderma renal crisis",
            "criterions": [
                {
                    "exact_snippets": "scleroderma renal crisis",
                    "criterion": "scleroderma renal crisis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a history of cervical or digital sympathectomy",
            "criterions": [
                {
                    "exact_snippets": "history of cervical or digital sympathectomy",
                    "criterion": "history of sympathectomy",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "cervical",
                                "digital"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a history of major trauma or hemorrhage",
            "criterions": [
                {
                    "exact_snippets": "history of major trauma",
                    "criterion": "major trauma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... hemorrhage",
                    "criterion": "hemorrhage",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have taken or are currently taking any parenteral, inhaled, or oral prostacyclin or prostacyclin receptor agonists",
            "criterions": [
                {
                    "exact_snippets": "Subjects who have taken or are currently taking any parenteral, inhaled, or oral prostacyclin or prostacyclin receptor agonists",
                    "criterion": "prostacyclin or prostacyclin receptor agonist use",
                    "requirements": [
                        {
                            "requirement_type": "route of administration",
                            "expected_value": [
                                "parenteral",
                                "inhaled",
                                "oral"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": [
                                "have taken",
                                "are currently taking"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with intractable diarrhea or vomiting",
            "criterions": [
                {
                    "exact_snippets": "intractable diarrhea",
                    "criterion": "diarrhea",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "intractable"
                        }
                    ]
                },
                {
                    "exact_snippets": "intractable ... vomiting",
                    "criterion": "vomiting",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "intractable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must not initiate dosing of oral, topical, or intravenous (IV) vasodilators or if currently receiving any vasodilator must have been stably medicated",
            "criterions": [
                {
                    "exact_snippets": "must not initiate dosing of oral, topical, or intravenous (IV) vasodilators",
                    "criterion": "vasodilator therapy initiation",
                    "requirements": [
                        {
                            "requirement_type": "initiation",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "if currently receiving any vasodilator must have been stably medicated",
                    "criterion": "current vasodilator therapy",
                    "requirements": [
                        {
                            "requirement_type": "stable medication",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with Child-Pugh Class B or Class C liver disease or an alanine aminotransferase and/or aspartate aminotransferase value >3 Ã— the upper limit of normal at screening.",
            "criterions": [
                {
                    "exact_snippets": "Child-Pugh Class B or Class C liver disease",
                    "criterion": "Child-Pugh class",
                    "requirements": [
                        {
                            "requirement_type": "class",
                            "expected_value": [
                                "B",
                                "C"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase ... value >3 Ã— the upper limit of normal at screening",
                    "criterion": "alanine aminotransferase (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "Ã— ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "aspartate aminotransferase value >3 Ã— the upper limit of normal at screening",
                    "criterion": "aspartate aminotransferase (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "Ã— ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with more than mild restrictive or congestive cardiomyopathy uncontrolled by medication or implanted device.",
            "criterions": [
                {
                    "exact_snippets": "more than mild restrictive or congestive cardiomyopathy",
                    "criterion": "restrictive or congestive cardiomyopathy",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "mild"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled by medication or implanted device",
                    "criterion": "restrictive or congestive cardiomyopathy control",
                    "requirements": [
                        {
                            "requirement_type": "control",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "treatment",
                            "expected_value": [
                                "medication",
                                "implanted device"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a history of hemodynamically significant aortic or mitral valve disease",
            "criterions": [
                {
                    "exact_snippets": "history of hemodynamically significant aortic or mitral valve disease",
                    "criterion": "aortic valve disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "hemodynamic significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of hemodynamically significant aortic or mitral valve disease",
                    "criterion": "mitral valve disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "hemodynamic significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have had any cerebrovascular events",
            "criterions": [
                {
                    "exact_snippets": "Subjects who have had any cerebrovascular events",
                    "criterion": "cerebrovascular events",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects who have used any investigational medication or device for any indication within 30 days or 5 half-lives (whichever is longer)",
            "criterions": [
                {
                    "exact_snippets": "Subjects who have used any investigational medication or device for any indication within 30 days or 5 half-lives (whichever is longer)",
                    "criterion": "use of investigational medication or device",
                    "requirements": [
                        {
                            "requirement_type": "recency of use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 30,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a history of life-threatening cardiac arrhythmias",
            "criterions": [
                {
                    "exact_snippets": "history of life-threatening cardiac arrhythmias",
                    "criterion": "cardiac arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "life-threatening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with a history of significant restrictive lung disease defined as forced vital capacity <45% predicted and diffusing capacity of the lungs for carbon monoxide <40% predicted (uncorrected for hemoglobin).",
            "criterions": [
                {
                    "exact_snippets": "history of significant restrictive lung disease",
                    "criterion": "restrictive lung disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "forced vital capacity <45% predicted",
                    "criterion": "forced vital capacity",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 45,
                                "unit": "% predicted"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "diffusing capacity of the lungs for carbon monoxide <40% predicted (uncorrected for hemoglobin)",
                    "criterion": "diffusing capacity of the lungs for carbon monoxide",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 40,
                                "unit": "% predicted"
                            }
                        },
                        {
                            "requirement_type": "correction for hemoglobin",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with any history of acetaminophen intolerability",
            "criterions": [
                {
                    "exact_snippets": "any history of acetaminophen intolerability",
                    "criterion": "acetaminophen intolerability",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Subjects with a history of myocardial infarction or unstable angina within 6 months of screening",
            "criterions": [
                {
                    "exact_snippets": "history of myocardial infarction within 6 months of screening",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... unstable angina within 6 months of screening",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}